Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

Abstract: the present invention provides methods for treating angiogenic eye disorders by sequentially administering multiple doses of a vegf antagonist to a patient. the methods of the present invention include the administration of multiple doses of a vegf antagonist to a patient at a frequency of once every 8 or more weeks. the methods of the present invention are useful for the treatment of angiogenic eye disorders such as age related macular degeneration, diabetic retinopathy, diabetic macular edema, central retinal vein occlusion, branch retinal vein occlusion, and corneal neovascularization.

Inventor(s): George D. YANCOPOULOS

CPC Classification: A61K38/179 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250152669